Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof

Details for Australian Patent Application No. 2006275784 (hide)

Owner Reliant Pharmaceuticals, Inc.

Inventors Bobotas, George; Rongen, Roelof M.L.

Agent Davies Collison Cave

Pub. Number AU-A-2006275784

PCT Pub. Number WO2007/016256

Priority 60/703,002 28.07.05 US

Filing date 28 July 2006

Wipo publication date 8 February 2007

International Classifications

A01N 37/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids

A61K 31/20 (2006.01)

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/016256 Priority application(s): WO2007/016256

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006275788-Devices and methods for controlling blood perfusion pressure using a retrograde cannula

2006275772-Fast carrier frequency error estimation algorithm using sychronization sequence